本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ADC Therapeutics SA

3.11
+0.07002.30%
盤後3.10-0.0100-0.32%18:51 EDT
成交量:35.59萬
成交額:111.14萬
市值:3.48億
市盈率:-2.14
高:3.17
開:3.05
低:3.05
收:3.04
資料載入中...
2023/12/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/04/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/04/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/21

SEC問詢函

CORRESP [Cover] - Correspondence
2023/03/16

SEC問詢函

Form CORRESP - Correspondence
2023/03/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/15

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/02

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/02/02

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/12/23

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/14

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/14

SEC問詢函

CORRESP [Cover] - Correspondence
2022/06/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/17

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals